stella
beta
Study of All-Trans Retinoic Acid (ATRA) and Cemiplimab in Patients With Advanced Leiomyosarcoma — Stella
Recruiting
Back to Leiomyosarcoma trials
Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations
(1 site)
United States
Ohio State University Comprehensive Cancer Center, Columbus, Ohio
View full record on ClinicalTrials.gov